0001781905-20-000005.txt : 20201110 0001781905-20-000005.hdr.sgml : 20201110 20201110163050 ACCESSION NUMBER: 0001781905-20-000005 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201110 DATE AS OF CHANGE: 20201110 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VIEMED HEALTHCARE, INC. CENTRAL INDEX KEY: 0001729149 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91292 FILM NUMBER: 201301574 BUSINESS ADDRESS: STREET 1: 625 E. KALISTE SALOOM RD. CITY: LAFAYETTE STATE: LA ZIP: 70508 BUSINESS PHONE: 337.504.3802 MAIL ADDRESS: STREET 1: 625 E. KALISTE SALOOM RD. CITY: LAFAYETTE STATE: LA ZIP: 70508 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Moore Michael CENTRAL INDEX KEY: 0001781905 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 202 N. LUKE ST. CITY: LAFAYETTE STATE: LA ZIP: 70506 SC 13G 1 schedule13g-michaelmooreoc.htm SC 13G Document

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934

(Amendment No. __)1

Viemed Healthcare, Inc.
(Name of Issuer)

Common Shares, No Par Value
(Title of Class of Securities)

92663R105
(CUSIP Number)

August 8, 2019
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 Rule 13d-1(b)
 Rule 13d-1(c)
Rule 13d-1(d)



1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
1



1.
NAMES OF REPORTING PERSONS    

Michael Moore
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)☐
(b)☒
3.SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION    United States
NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH		5.SOLE VOTING POWER1,893,584
6.SHARED VOTING POWER0
7.SOLE DISPOSITIVE POWER1,893,584
8.SHARED DISPOSITIVE POWER0
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,893,584 shares of Common Stock
10.CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
    
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)    4.8%2
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)    IN

2 Assumes 39,145,182 Common Shares of the Company outstanding as of October 31, 2020, based on information contained in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2020.
2



Item 1.        

(a)Name of Issuer - Viemed Healthcare, Inc., an entity incorporated pursuant to the Business Corporations Act (British Columbia) (the “Issuer”).

(b)Address of Issuer’s Principal Executive Offices - 625 E. Kaliste Saloom Rd, Lafayette, Louisiana 70508.

Item 2.        

(a)Name of Person Filing – Michael Moore (“Moore”), a natural person.

(b)Address of Principal Business Office or, if none, Residence - 625 E. Kaliste Saloom Rd, Lafayette, Louisiana 70508.

(c)Citizenship - United States of America.

(d)Title of Class of Securities - Common shares, no par value, (the “Common Shares”) of the Issuer.

(e)CUSIP Number - 92663R105.

Item 3.        If this Statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c).

Not applicable.
Item 4.         Ownership.

The percentages used herein are calculated based on 39,145,182 Common Shares issued and outstanding as of October 6, 2020, based on information publicly disclosed by the Issuer.

(a)Amount beneficially owned – Moore beneficially owns 1,893,584 Common Shares, which amount includes 156,101 shares issuable upon the exercise of options that are vested or will vest within 60 days.

(b)Percent of class – 4.8%.

(c)Number of shares as to which the person has:

i.Sole power to vote or to direct the vote: 1,893,584

ii.Shared power to vote or direct the vote: 0

iii.Sole power to dispose or to direct the disposition of: 1,893,584

iv.Shared power to dispose or to direct the disposition of: 0

Item 5.         Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following .

3



Item 6.    Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.        Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not applicable.

Item 8.        Identification and Classification of the Members of the Group.

Not applicable.

Item 9.        Notice of Dissolution of Group.

Not applicable.

Item 10.    Certifications.

Not applicable.


































4




SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date:    November 10, 2020



    /s/ Michael Moore    
Michael Moore



5